Position in ABBV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$25,729,278
-$3,555,136 QoQ
Shares Held
118,301
-7.7% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Advisory Services Network, LLC holds $159,480,021 across 17 Drug Manufacturers - General names. ABBV ranks #2 (16.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
50,669 | $46,603,818 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
118,301 | $25,729,278 | |
| 3 | JNJ |
Johnson & Johnson
|
86,066 | $21,037,966 | |
| 4 | MRK |
Merck & Co., Inc.
|
143,304 | $17,238,032 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
74,137 | $10,332,465 | |
| 6 | AMGN |
Amgen Inc
|
29,101 | $10,239,178 | |
| 7 | PFE |
Pfizer Inc
|
258,469 | $7,257,803 | |
| 8 | NVS |
Novartis AG
|
38,689 | $5,909,741 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $25,729,278 | 118,301 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $29,284,414 | 128,165 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $29,012,649 | 125,303 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $25,444,967 | 137,081 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $26,200,049 | 125,048 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $21,058,866 | 118,508 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $27,891,675 | 141,238 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $24,225,137 | 141,238 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $24,411,776 | 134,057 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $17,229,095 | 111,177 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $18,097,370 | 121,410 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $17,871,392 | 132,646 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $21,549,688 | 135,218 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $20,710,802 | 128,153 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $17,863,616 | 133,102 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $20,027,812 | 130,764 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $17,117,353 | 105,591 | Shares | Sole | 2022-05-23 | |
| 2021-12-31 | $14,498,360 | 107,078 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $10,772,003 | 99,861 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $11,439,490 | 101,558 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $9,603,656 | 88,742 | Shares | Sole | 2021-05-24 | |
| 2020-12-31 | $8,867,089 | 82,754 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $7,702,485 | 87,938 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $8,943,310 | 91,091 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $5,971,387 | 78,375 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||